These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 27007263

  • 21. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K, Drimtzias E, Picton S, Simmons I.
    Br J Ophthalmol; 2018 Oct; 102(10):1367-1371. PubMed ID: 29343527
    [Abstract] [Full Text] [Related]

  • 22. Optic pathway glioma and the sex association in neurofibromatosis type 1: a single-center study.
    Henning AM, Handrup MM, Kjeldsen SM, Larsen DA, Ejerskov C.
    Orphanet J Rare Dis; 2021 Nov 22; 16(1):489. PubMed ID: 34809690
    [Abstract] [Full Text] [Related]

  • 23. Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome.
    Borghei-Razavi H, Shibao S, Schick U.
    Neurosurg Rev; 2017 Jan 22; 40(1):135-141. PubMed ID: 27230830
    [Abstract] [Full Text] [Related]

  • 24. Optic pathway gliomas in children with and without neurofibromatosis 1.
    Czyzyk E, Jóźwiak S, Roszkowski M, Schwartz RA.
    J Child Neurol; 2003 Jul 22; 18(7):471-8. PubMed ID: 12940652
    [Abstract] [Full Text] [Related]

  • 25. NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.
    Azizi AA, Walker DA, Liu JF, Sehested A, Jaspan T, Pemp B, Simmons I, Ferner R, Grill J, Hargrave D, Driever PH, Evans DG, Opocher E, SIOPE NF1 OPG Nottingham, UK, Workshop 2014.
    Neuro Oncol; 2021 Jan 30; 23(1):100-111. PubMed ID: 32628746
    [Abstract] [Full Text] [Related]

  • 26. Optic Gliomas in Neurofibromatosis Type 1.
    Parkhurst E, Abboy S.
    J Pediatr Ophthalmol Strabismus; 2016 Nov 01; 53(6):334-338. PubMed ID: 27537249
    [Abstract] [Full Text] [Related]

  • 27. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
    Cambiaso P, Galassi S, Palmiero M, Mastronuzzi A, Del Bufalo F, Capolino R, Cacchione A, Buonuomo PS, Gonfiantini MV, Bartuli A, Cappa M, Macchiaiolo M.
    Am J Med Genet A; 2017 Sep 01; 173(9):2353-2358. PubMed ID: 28631895
    [Abstract] [Full Text] [Related]

  • 28. The role of visual electrodiagnostics in management of children with neurofibromatosis type 1.
    Tekavčič Pompe M, Pečarič Meglič N, Šuštar Habjan M.
    Doc Ophthalmol; 2023 Apr 01; 146(2):121-136. PubMed ID: 36652041
    [Abstract] [Full Text] [Related]

  • 29. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
    Avery RA, Bouffet E, Packer RJ, Reginald A.
    Invest Ophthalmol Vis Sci; 2013 Feb 05; 54(2):1034-8. PubMed ID: 23329671
    [Abstract] [Full Text] [Related]

  • 30. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M, Opocher E, Viscardi E, Calderone M, Severino SM, Cermakova I, Perilongo G.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1083-8. PubMed ID: 20979170
    [Abstract] [Full Text] [Related]

  • 31. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma.
    Boonzaier NR, Hales PW, D'Arco F, Walters BC, Kaur R, Mankad K, Cooper J, Liasis A, Smith V, O'Hare P, Hargrave D, Clark CA.
    Neuroimage Clin; 2020 Dec 01; 28():102447. PubMed ID: 33038669
    [Abstract] [Full Text] [Related]

  • 32. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S, Baumann-Schröder U, Hazim W, Haase W, Mautner VF.
    Klin Monbl Augenheilkd; 1999 Dec 01; 215(6):349-54. PubMed ID: 10637799
    [Abstract] [Full Text] [Related]

  • 33. Longitudinal measures of visual function, tumor volume, and prediction of visual outcomes after treatment of optic pathway gliomas.
    Kelly JP, Leary S, Khanna P, Weiss AH.
    Ophthalmology; 2012 Jun 01; 119(6):1231-7. PubMed ID: 22364864
    [Abstract] [Full Text] [Related]

  • 34. Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?
    Maloney E, Stanescu AL, Perez FA, Iyer RS, Otto RK, Leary S, Steuten L, Phipps AI, Shaw DWW.
    Pediatr Radiol; 2018 Sep 01; 48(10):1472-1484. PubMed ID: 29789890
    [Abstract] [Full Text] [Related]

  • 35. Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence.
    Moreno L, Bautista F, Ashley S, Duncan C, Zacharoulis S.
    Eur J Cancer; 2010 Aug 01; 46(12):2253-9. PubMed ID: 20400294
    [Abstract] [Full Text] [Related]

  • 36. Isolated optic nerve gliomas: a multicenter historical cohort study.
    Shofty B, Ben-Sira L, Kesler A, Jallo G, Groves ML, Iyer RR, Lassaletta A, Tabori U, Bouffet E, Thomale UW, Hernáiz Driever P, Constantini S, Isolated Optic Nerve Abnormalities (IONA) Collaboration.
    J Neurosurg Pediatr; 2017 Dec 01; 20(6):549-555. PubMed ID: 28984541
    [Abstract] [Full Text] [Related]

  • 37. [Prognostic factors of neurofibromatosis type 1-associated optic pathway gliomas in children].
    Florent C, Beylerian M, Mairot K, Dambricourt L, André N, David T, Girard N, Audic F, Denis D.
    J Fr Ophtalmol; 2022 Feb 01; 45(2):173-184. PubMed ID: 34972579
    [Abstract] [Full Text] [Related]

  • 38. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
    Avery RA, Mansoor A, Idrees R, Biggs E, Alsharid MA, Packer RJ, Linguraru MG.
    Neurology; 2016 Jun 14; 86(24):2264-70. PubMed ID: 27170570
    [Abstract] [Full Text] [Related]

  • 39. Orbital optic nerve gliomas in children with neurofibromatosis type 1.
    Zeid JL, Charrow J, Sandu M, Goldman S, Listernick R.
    J AAPOS; 2006 Dec 14; 10(6):534-9. PubMed ID: 17189147
    [Abstract] [Full Text] [Related]

  • 40. Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1.
    Kotch C, Avery R, Getz KD, Bouffet E, de Blank P, Listernick R, Gutmann DH, Bornhorst M, Campen C, Liu GT, Aplenc R, Li Y, Fisher MJ.
    Neuro Oncol; 2022 Aug 01; 24(8):1377-1386. PubMed ID: 35018469
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.